Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Aug;4(4):413–425. doi: 10.1111/j.1365-2125.1977.tb00756.x

The assessment of beta-adrenoceptor blocking drugs in man.

D G McDevitt
PMCID: PMC1429044  PMID: 20123

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelmann W. H., Fareeduddin K. Increased tolerance of orthostatic stress in patients with heart disease. Am J Cardiol. 1969 Mar;23(3):354–363. doi: 10.1016/0002-9149(69)90515-3. [DOI] [PubMed] [Google Scholar]
  2. Blinks J. R. Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):673–685. doi: 10.1111/j.1749-6632.1967.tb41237.x. [DOI] [PubMed] [Google Scholar]
  3. Bodem G., Chidsey C. A. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26–29. doi: 10.1002/cpt197314126. [DOI] [PubMed] [Google Scholar]
  4. Bourne H. R., Thomson P. D., Melmon K. L. Diagnosis and treatment of beta-adrenergic receptor hyperresponsiveness. A critical appraisal. Arch Intern Med. 1970 Jun;125(6):1063–1066. [PubMed] [Google Scholar]
  5. Briant R. H., Dollery C. T., Fenyvesi T., George C. F. Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol. 1973 Sep;49(1):106–114. doi: 10.1111/j.1476-5381.1973.tb08272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown H. C., Carruthers S. G., Johnston G. D., Kelly J. G., McAinsh J., McDevitt D. G., Shanks R. G. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther. 1976 Nov;20(5):524–534. doi: 10.1002/cpt1976205524. [DOI] [PubMed] [Google Scholar]
  7. Brown H. C., Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367–372. doi: 10.1007/BF00606550. [DOI] [PubMed] [Google Scholar]
  8. COOKSON D. U., REED C. E. A COMPARISON OF THE EFFECTS OF ISOPROTERENOL IN THE NORMAL AND ASTHMATIC SUBJECT. A PRELIMINARY REPORT. Am Rev Respir Dis. 1963 Nov;88:636–643. doi: 10.1164/arrd.1963.88.5.636. [DOI] [PubMed] [Google Scholar]
  9. Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther. 1974 May;15(5):497–509. doi: 10.1002/cpt1974155497. [DOI] [PubMed] [Google Scholar]
  10. Chamberlain D. A., Turner P., Sneddon J. M. Effects of atropine on heart-rate in healthy man. Lancet. 1967 Jul 1;2(7505):12–15. doi: 10.1016/s0140-6736(67)90057-8. [DOI] [PubMed] [Google Scholar]
  11. Cleaveland C. R., Rangno R. E., Shand D. G. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med. 1972 Jul;130(1):47–52. doi: 10.1001/archinte.130.1.47. [DOI] [PubMed] [Google Scholar]
  12. Cleaveland C. R., Shand D. G. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181–185. doi: 10.1002/cpt1972132181. [DOI] [PubMed] [Google Scholar]
  13. Coltart D. J., Gibson D. G., Shand D. G. Plasma propranolol levels associated with suppression of ventricular ectopic beats. Br Med J. 1971 Feb 27;1(5747):490–491. doi: 10.1136/bmj.1.5747.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Coltart D. J., Meldrum S. J., Hamer J. The effect of propranolol on the human and canine transmembrane action potential. Br J Pharmacol. 1970 Sep;40(1):148P–149P. [PMC free article] [PubMed] [Google Scholar]
  15. Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Conolly M. E., Davies D. S., Dollery C. T., George C. F. Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol. 1971 Oct;43(2):389–402. [PMC free article] [PubMed] [Google Scholar]
  17. Cuthbert M. F., Collins R. F. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man. Br J Clin Pharmacol. 1975 Feb;2(1):49–55. doi: 10.1111/j.1365-2125.1975.tb00471.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Donald D. E. Myocardial performance after excision of the extrinsic cardiac nerves in the dog. Circ Res. 1974 Apr;34(4):417–424. doi: 10.1161/01.res.34.4.417. [DOI] [PubMed] [Google Scholar]
  19. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Eckberg D. L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971 Oct 14;285(16):877–883. doi: 10.1056/NEJM197110142851602. [DOI] [PubMed] [Google Scholar]
  21. Evans G. H., Nies A. S., Shand D. G. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. J Pharmacol Exp Ther. 1973 Jul;186(1):114–122. [PubMed] [Google Scholar]
  22. Fitzgerald J. D. A new test of the degree of adrenergic beta receptor blockade. Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):125–130. [PubMed] [Google Scholar]
  23. Fitzgerald J. D., O'Donnell S. R. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Br J Pharmacol. 1971 Sep;43(1):222–235. doi: 10.1111/j.1476-5381.1971.tb07171.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fitzgerald J. D., Scales B. Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels. Int Z Klin Pharmakol Ther Toxikol. 1968;1(6):467–474. [PubMed] [Google Scholar]
  25. Frohlich E. D., Tarazi R. C., Dustan H. P. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med. 1969 Jan;123(1):1–7. [PubMed] [Google Scholar]
  26. George C. F., Conolly M. E., Fenyvesi T., Briant R., Dollery C. T. Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med. 1972 Sep;130(3):361–364. [PubMed] [Google Scholar]
  27. George C. F., Fenyvesi T., Conolly M. E., Dollery C. T. Pharmacokinetics of dextro-, laevo- and racemic propranolol in man. Eur J Clin Pharmacol. 1972 Mar;4(2):74–76. doi: 10.1007/BF00562500. [DOI] [PubMed] [Google Scholar]
  28. George C. F. Problems in assessing beta-adrenoceptor antagonism in man. Br J Clin Pharmacol. 1975 Feb;2(1):3–4. doi: 10.1111/j.1365-2125.1975.tb01690.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Harry J. D., Knapp M. F., Linden R. J., Newcombe C. P., Stoker J. B. A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings]. Br J Clin Pharmacol. 1975 Aug;2(4):374P–374P. [PubMed] [Google Scholar]
  30. Jackson G., Atkinson L., Oram S. Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements. Br Med J. 1975 Sep 13;3(5984):616–618. doi: 10.1136/bmj.3.5984.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Johnsson G., Svedmyr N., Thiringer G. Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):175–180. doi: 10.1007/BF00567111. [DOI] [PubMed] [Google Scholar]
  32. Jose A. D. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol. 1966 Sep;18(3):476–478. doi: 10.1016/0002-9149(66)90073-7. [DOI] [PubMed] [Google Scholar]
  33. Kumana C. R., Kaye C. M., Leighton M., Turner P., Hamer J. Cardiac and pulmonary effects of acebutolol. Lancet. 1975 Jul 19;2(7925):89–93. doi: 10.1016/s0140-6736(75)90001-x. [DOI] [PubMed] [Google Scholar]
  34. Kumana C. R., Marlin G. E., Kaye C. M., Smith D. M. New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J. 1974 Nov 23;4(5942):444–447. doi: 10.1136/bmj.4.5942.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. LIND A. R., TAYLOR S. H., HUMPHREYS P. W., KENNELLY B. M., DONALD K. W. THE CIRCULATIORY EFFECTS OF SUSTAINED VOLUNTARY MUSCLE CONTRACTION. Clin Sci. 1964 Oct;27:229–244. [PubMed] [Google Scholar]
  36. Lands A. M., Luduena F. P., Buzzo H. J. Differentiation of receptors responsive to isoproterenol. Life Sci. 1967 Nov 1;6(21):2241–2249. doi: 10.1016/0024-3205(67)90031-8. [DOI] [PubMed] [Google Scholar]
  37. Lertora J. J., Mark A. L., Johannsen J., Wilson W. R., Abboud F. M. Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest. 1975 Sep;56(3):719–724. doi: 10.1172/JCI108143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. London G. M., Safar M. E., Weiss Y. A., Milliez P. L. Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients. J Clin Pharmacol. 1976 Apr;16(4):174–183. doi: 10.1002/j.1552-4604.1976.tb01514.x. [DOI] [PubMed] [Google Scholar]
  39. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. MacDonald H. R., Sapru R. P., Taylor S. H., Donald K. W. Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip. Am J Cardiol. 1966 Sep;18(3):333–344. doi: 10.1016/0002-9149(66)90051-8. [DOI] [PubMed] [Google Scholar]
  41. McDevitt D. G., Brown H. C., Carruthers S. G., Shanks R. G. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther. 1977 May;21(5):556–566. doi: 10.1002/cpt1977215556. [DOI] [PubMed] [Google Scholar]
  42. McDevitt D. G., Frisk-Holmberg M., Hollifield J. W., Shand D. G. Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther. 1976 Aug;20(2):152–157. doi: 10.1002/cpt1976202152. [DOI] [PubMed] [Google Scholar]
  43. McDevitt D. G., Shand D. G. Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther. 1975 Dec;18(6):708–713. doi: 10.1002/cpt1975186708. [DOI] [PubMed] [Google Scholar]
  44. Nelson J. K., McDevitt D. G. Comparative trial of propranolol and practolol in hyperthyroidism. Br J Clin Pharmacol. 1975 Oct;2(5):411–416. doi: 10.1111/j.1365-2125.1975.tb00549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Nigam P. D., Malhotra A. S. Prolonged action of pindolol. Br Med J. 1973 Mar 24;1(5855):742–743. doi: 10.1136/bmj.1.5855.742-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
  47. Perrier D., Gibaldi M. Drug concentrations in the plasma as an index of pharmacologic effect. J Clin Pharmacol. 1974 Aug-Sep;14(8):415–417. doi: 10.1002/j.1552-4604.1974.tb02322.x. [DOI] [PubMed] [Google Scholar]
  48. Powles R., Shinebourne E., Hamer J. Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy. Thorax. 1969 Sep;24(5):616–618. doi: 10.1136/thx.24.5.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. ROBINSON S., PEARCY M., BRUECKMAN F. R., NICHOLAS J. R., MILLER D. I. Effects of atropine on heart rate and oxygen intake in working man. J Appl Physiol. 1953 Mar;5(9):508–512. doi: 10.1152/jappl.1953.5.9.508. [DOI] [PubMed] [Google Scholar]
  50. Riegelman S., Loo J. C., Rowland M. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci. 1968 Jan;57(1):117–123. doi: 10.1002/jps.2600570123. [DOI] [PubMed] [Google Scholar]
  51. Robinson B. F., Epstein S. E., Beiser G. D., Braunwald E. Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res. 1966 Aug;19(2):400–411. doi: 10.1161/01.res.19.2.400. [DOI] [PubMed] [Google Scholar]
  52. Shanks R. G. The pharmacology of beta sympathetic blockade. Am J Cardiol. 1966 Sep;18(3):308–316. doi: 10.1016/0002-9149(66)90047-6. [DOI] [PubMed] [Google Scholar]
  53. Turner P. Beta-adrenergic receptor blocking drugs in hyperthyroidism. Drugs. 1974;7(1):48–54. doi: 10.2165/00003495-197407010-00004. [DOI] [PubMed] [Google Scholar]
  54. Viljoen J. F., Estafanous F. G., Kellner G. A. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972 Nov;64(5):826–830. [PubMed] [Google Scholar]
  55. Vilsvik J. S., Schaanning J. Effect of atenolol on ventilatory and cardiac function in asthma. Br Med J. 1976 Aug 21;2(6033):453–455. doi: 10.1136/bmj.2.6033.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wiener L., Dwyer E. M., Jr, Cox J. W. Hemodynamic effects of nitroglycerin, propranolol, and their combination in coronary heart disease. Circulation. 1969 May;39(5):623–632. doi: 10.1161/01.cir.39.5.623. [DOI] [PubMed] [Google Scholar]
  57. Zacest R., Koch-Weser J. Relation of propranolol plasma level to beta-blockade during oral therapy. Pharmacology. 1972;7(3):178–184. doi: 10.1159/000136287. [DOI] [PubMed] [Google Scholar]
  58. Zweifler A. J., Hansson L. Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of the nitroglycerin test. Clin Pharmacol Ther. 1976 Apr;19(4):403–409. doi: 10.1002/cpt1976194403. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES